Evidence map›Paper›PMID 32755587›Full record

ArticleCell reports2020

A Switch in p53 Dynamics Marks Cells That Escape from DSB-Induced Cell Cycle Arrest.

Michael Tsabar, Caroline S Mock, Veena Venkatachalam, Jose Reyes, Kyle W Karhohs, Trudy G Oliver, Aviv Regev, Ashwini Jambhekar, Galit Lahav

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Moonlighting at the Poles: Non-Canonical Functions of Centrosomes.Frontiers in cell and developmental biology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Michael TsabarDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Caroline S MockDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Veena VenkatachalamDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA 02115, USA.
Jose ReyesDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Kyle W KarhohsDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Trudy G OliverHuntsman Cancer Institute at University of Utah, Salt Lake City, UT 84112, USA.
Aviv RegevBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Ashwini JambhekarDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Galit LahavDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: galit@hms.harvard.edu.
Center for Systems Biology · USHarvard University · USBroad Institute · USHuntsman Cancer Institute · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Center for Cell CircuitsRM1HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI BLAINEY, PAUL CLARK, HACOHEN, NIR · 2016 to 2020
$14.9M
Dynamics of Signaling Pathways: Mechanism and FunctionR01GM083303 · NIGMS · HARVARD MEDICAL SCHOOL · PI LAHAV, GALIT · 2008 to 2020
$5.2M
Dynamics of Cellular Senescence in Single CellsR01GM116864 · NIGMS · HARVARD MEDICAL SCHOOL · PI LAHAV, GALIT · 2017 to 2020
$1.6M
NHGRI NIH HHS RM1 HG006193NIGMS NIH HHS R01 GM083303NIGMS NIH HHS R01 GM116864NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Cellular responses to stimuli can evolve over time, resulting in distinct early and late phases in response to a single signal. DNA damage induces a complex response that is largely orchestrated by the transcription factor p53, whose dynamics influence whether a damaged cell will arrest and repair the damage or will initiate cell death. How p53 responses and cellular outcomes evolve in the presence of continuous DNA damage remains unknown. Here, we have found that a subset of cells switches from oscillating to sustained p53 dynamics several days after undergoing damage. The switch results from cell cycle progression in the presence of damaged DNA, which activates the caspase-2-PIDDosome, a complex that stabilizes p53 by inactivating its negative regulator MDM2. This work defines a molecular pathway that is activated if the canonical checkpoints fail to halt mitosis in the presence of damaged DNA.

Indexed as

Cell Cycle CheckpointsDNA Breaks, Double-StrandedA549 CellsCaspase 2Death Domain Receptor Signaling Adaptor ProteinsHumansMCF-7 CellsMitosisModels, BiologicalProteolysisProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53Ultraviolet RaysCaspase 2Death Domain Receptor Signaling Adaptor ProteinsPIDD1 protein, humanProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53caspase-2DNA damagedynamicsimagingp53Pidd1PIDDosomesingle-cells

Identifiers

PMID32755587
PMCPMC7521664
OpenAlexW3047238869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.